Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.

Kosaku MimuraTakashi OgataYuya YoshimotoDaisaku YoshidaShotaro NakajimaHisashi SatoNozomu MachidaTakanobu YamadaYohei WatanabeTomoaki TamakiHirohito FujikawaYasuhiro InokuchiSuguru HayaseHiroyuki HanayamaZenichiro SazeHiroyuki KatohFumiaki TakahashiTakashi OshimaYoshiyuki SuzukiKoji Kono

Published in: Communications medicine (2023)

The present study suggests that the combination of nivolumab with oligo-fractionated irradiation has the potential to induce a promising anti-tumor effect for advanced GC.

Keyphrases

clinical trial
radiation induced
open label
small cell lung cancer
randomized controlled trial
brain metastases
radiation therapy
human health
high resolution
phase iii
gas chromatography
simultaneous determination
tandem mass spectrometry